|
1
|
Zanetti M, Gennaro R, Scocchi M and
Skerlavaj B: Structure and biology of cathelicidins. Adv Exp Med
Biol. 479:203–218. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zanetti M: The role of cathelicidins in
the innate host defenses of mammals. Curr Issues Mol Biol.
7:179–196. 2005.PubMed/NCBI
|
|
3
|
Cowland JB, Johnsen AH and Borregaard N:
hCAP-18, a cathelin/probactenecin-like protein of human neutrophil
specific granules. FEBS Lett. 368:173–176. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frohm M, Agerberth B, Ahangari G,
Ståhle-Bäckdahl M, Lidén S, Wigzell H and Gudmundsson GH: The
expression of the gene coding for the antibacterial peptide LL-37
is induced in human keratinocytes during inflammatory disorders. J
Biol Chem. 272:15258–15263. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bals R, Wang X, Zasloff M and Wilson JM:
The peptide anti-biotic LL-37/hCAP-18 is expressed in epithelia of
the human lung where it has broad antimicrobial activity at the
airway surface. Proc Natl Acad Sci USA. 95:9541–9546. 1998.
View Article : Google Scholar
|
|
6
|
Hase K, Eckmann L, Leopard JD, Varki N and
Kagnoff MF: Cell differentiation is a key determinant of
cathelicidin LL-37/human cationic antimicrobial protein 18
expression by human colon epithelium. Infect Immun. 70:953–963.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren SX, Cheng AS, To KF, Tong JH, Li MS,
Shen J, Wong CC, Zhang L, Chan RL, Wang XJ, et al: Host immune
defense peptide LL-37 activates caspase-independent apoptosis and
suppresses colon cancer. Cancer Res. 72:6512–6523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
PDQ Adult Treatment and Editorial Board:
Colon Cancer Treatment (PDQ®): Patient Version PDQ Cancer
Information Summaries edn. Bethesda (MD): National Cancer Institute
(US); 2002
|
|
10
|
Okumura K, Itoh A, Isogai E, Hirose K,
Hosokawa Y, Abiko Y, Shibata T, Hirata M and Isogai H: C-terminal
domain of human CAP18 antimicrobial peptide induces apoptosis in
oral squamous cell carcinoma SAS-H1 cells. Cancer Lett.
212:185–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuroda K, Fukuda T, Yoneyama H, Katayama
M, Isogai H, Okumura K and Isogai E: Anti-proliferative effect of
an analogue of the LL-37 peptide in the colon cancer derived cell
line HCT 116 p53+/+ and p53−/−. Oncol Rep. 28:829–834. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuroda K, Fukuda T, Krstic-Demonacos M,
Demonacos C, Okumura K, Isogai H, Hayashi M, Saito K and Isogai E:
miR-663a regulates growth of colon cancer cells, after
administration of antimicrobial peptides, by targeting CXCR4-p21
pathway. BMC Cancer. 17:332017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O’Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer Cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Redis RS, Calin S, Yang Y, You MJ and
Calin GA: Cell-to-cell miRNA transfer: From body homeostasis to
therapy. Pharmacol Ther. 136:169–174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Zheng W, Guo Z, Ju Q, Zhu L, Gao J,
Zhou L, Liu F, Xu Y, Zhan Q, et al: A novel TP53 pathway influences
the HGS-mediated exosome formation in colorectal cancer. Sci Rep.
6:280832016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zaharie F, Muresan MS, Petrushev B, Berce
C, Gafencu GA, Selicean S, Jurj A, Cojocneanu-Petric R, Lisencu CI,
Pop LA, et al: Exosome-carried microRNA-375 inhibits cell
progression and dissemination via Bcl-2 blocking in colon cancer. J
Gastrointest Liver Dis. 24:435–443. 2015.
|
|
23
|
Kuroda K, Fukuda T, Isogai H, Okumura K,
Krstic-Demonacos M and Isogai E: Antimicrobial peptide FF/CAP18
induces apoptotic cell death in HCT116 colon cancer cells via
changes in the metabolic profile. Int J Oncol. 46:1516–1526. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu WK, Wang G, Coffelt SB, Betancourt AM,
Lee CW, Fan D, Wu K, Yu J, Sung JJ and Cho CH: Emerging roles of
the host defense peptide LL-37 in human cancer and its potential
therapeutic applications. Int J Cancer. 127:1741–1747. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuroda K, Okumura K, Isogai H and Isogai
E: The human cathelicidin antimicrobial peptide LL-37 and mimics
are potential anticancer drugs. Front Oncol. 5:1442015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Neville F, Cahuzac M, Konovalov O,
Ishitsuka Y, Lee KYC, Kuzmenko I, Kale GM and Gidalevitz D: Lipid
headgroup discrimination by antimicrobial peptide LL-37: Insight
into mechanism of action. Biophys J. 90:1275–1287. 2006. View Article : Google Scholar
|
|
27
|
Turner J, Cho Y, Dinh NN, Waring AJ and
Lehrer RI: Activities of LL-37, a cathelin-associated antimicrobial
peptide of human neutrophils. Antimicrob Agents Chemother.
42:2206–2214. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shahmiri M, Enciso M, Adda CG, Smith BJ,
Perugini MA and Mechler A: Membrane core-specific antimicrobial
action of cathelicidin LL-37 peptide switches between pore and
nanofibre formation. Sci Rep. 6:381842016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Savina A, Furlán M, Vidal M and Colombo
MI: Exosome release is regulated by a calcium-dependent mechanism
in K562 cells. J Biol Chem. 278:20083–20090. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Safaei R, Larson BJ, Cheng TC, Gibson MA,
Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking
and enhanced exosomal export of cisplatin in drug-resistant human
ovarian carcinoma cells. Mol Cancer Ther. 4:1595–1604. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Li, Wei ZQ, Wang S, Chen W, Zhang Z,
Chen L, Li L, Sun B, Xu GJ, et al: Overexpression of miR-584 5p
inhibits proliferation and induces apoptosis by targeting WW
domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
J Exp Clin Cancer Res. 36:592017. View Article : Google Scholar
|
|
32
|
Konishi H, Fujiya M, Ueno N, Moriichi K,
Sasajima J, Ikuta K, Tanabe H, Tanaka H and Kohgo Y: microRNA-26a
and -584 inhibit the colorectal cancer progression through
inhibition of the binding of hnRNP A1-CDK6 mRNA. Biochem Biophys
Res Commun. 467:847–852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nam EJ, Lee M, Yim GW, Kim JH, Kim S, Kim
SW and Kim YT: MicroRNA profiling of a CD133+
spheroid-forming subpopulation of the OVCAR3 human ovarian cancer
cell line. BMC Med Genomics. 5:182012. View Article : Google Scholar
|
|
34
|
Munari E, Marchionni L, Chitre A, Hayashi
M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO,
et al: Clear cell papillary renal cell carcinoma: micro-RNA
expression profiling and comparison with clear cell renal cell
carcinoma and papillary renal cell carcinoma. Hum Pathol.
45:1130–1138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Quan Y, Song Q, Wang J, Zhao L, Lv J and
Gong S: MiR-1202 functions as a tumor suppressor in glioma cells by
targeting Rab1A. Tumor Biol. 39:1010428317697562017. View Article : Google Scholar
|
|
36
|
Meehan K and Vella LJ: The contribution of
tumour-derived exosomes to the hallmarks of cancer. Crit Rev Clin
Lab Sci. 53:121–131. 2016. View Article : Google Scholar
|
|
37
|
Lai RC, Chen TS and Lim SK: Mesenchymal
stem cell exosome: A novel stem cell-based therapy for
cardiovascular disease. Regen Med. 6:481–492. 2011. View Article : Google Scholar : PubMed/NCBI
|
